Simparica is a drug owned by ZOETIS INC. It is protected by 4 US drug patents filed from 2032 to 2033. All patents are active. Details of Simparica’s patents and their expiration are given below.
Exclusivity Information
Simparica holds 2 exclusivitys out of which 2 have expired. Details of Simparica's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Feb 24, 2021 |
| NCI | May 18, 2024 |
About Simparica
Simparica is a drug
owned by ZOETIS INC.
Simparica uses
Sarolaner as the active
ingredient.
Active Ingredient:
Simparica uses
Sarolaner as the active ingredient.
Check out other Drugs and Companies using
Sarolaner ingredient.